Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '252.501.09

Profile

Edit
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
URL https://www.esperion.com
Investor Relations URL https://www.esperion.com/investors-media
HQ State/Province Michigan
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release May. 06, 2025
Last Earnings Release Mar. 04, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Edit
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
URL https://www.esperion.com
Investor Relations URL https://www.esperion.com/investors-media
HQ State/Province Michigan
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release May. 06, 2025
Last Earnings Release Mar. 04, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A
Quickflows